Paper2643772
Comparison of high-dose with low-dose subcutaneous heparin to prevent left ventricular mural thrombosis in patients with acute transmural anterior myocardial infarction.
Turpie AG and 9 others. N Engl J Med, 1989. Cited by 283 papers, by iCite.
Cite this record
ConductScience Library. Comparison of high-dose with low-dose subcutaneous heparin to prevent left ventricular mural thrombosis in patients with acute transmural anterior myocardial infarction. Papers, record 2643772. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2643772
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Comparison of high-dose with low-dose subcutaneous heparin to prevent left ventricular mural thrombosis in patients with acute transmural anterior myocardial infarction.
- PubMed
- Publication types
- Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Coronary Disease | Major topic |
| Coronary Thrombosis | Major topic |
| Heparin | Major topic |
| Myocardial Infarction | Major topic |
| Aged | |
| Clinical Trials as Topic | |
| Double-Blind Method | |
| Echocardiography | |
| Female | |
| Follow-Up Studies | |
| Hemorrhage | |
| Humans | |
| Injections, Subcutaneous | |
| Male | |
| Partial Thromboplastin Time | |
| Random Allocation |
Source PubMed
Trials3
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT03415386 | Optimized Antithrombotic Therapy of Acute Myocardial Infarction With Left Ventricular Mural Thrombus | Background | ClinicalTrials.gov | |
| NCT04829825 | The "MyoThrombus" Study | Background | ClinicalTrials.gov | |
| NCT05006677 | Effectiveness and Safety of Different Antithrombotic Therapy for the Treatment of Ventricular Thrombus | Background | ClinicalTrials.gov |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 2747763 | Heparin for mural thrombosis in anterior myocardial infarction. | https://conductscience.org/library/papers/2747763 |
Source PubMed
Cited by53
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 283 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39938942 | Advancing clinical management of left ventricular thrombosis: prevention, detection and treatment modalities in the modern era. | Heart | 2025 | https://conductscience.org/library/papers/39938942 | PubMed |
| 39850087 | Carbon dots with red emission as nanoprobe for sensing of heparin in biofluids and pharmaceutical samples. | RSC Adv | 2025 | https://conductscience.org/library/papers/39850087 | PubMed |
| 39076895 | A Meta-Analysis Comparing Different Oral Anticoagulation for the Treatment of Ventricular Thrombus. | Rev Cardiovasc Med | 2022 | https://conductscience.org/library/papers/39076895 | PubMed |
| 35685496 | Different Oral Antithrombotic Therapy for the Treatment of Ventricular Thrombus: An Observational Study from 2010 to 2019. | Int J Clin Pract | 2022 | https://conductscience.org/library/papers/35685496 | PubMed |
| 34420077 | Rivaroxaban versus Vitamin K Antagonists (warfarin) based on the triple therapy for left ventricular thrombus after ST-Elevation myocardial infarction. | Heart Vessels | 2022 | https://conductscience.org/library/papers/34420077 | PubMed |
| 33850917 | Management of left ventricular thrombus: a narrative review. | Ann Transl Med | 2021 | https://conductscience.org/library/papers/33850917 | PubMed |
| 29985433 | Comparison of Systematic Ticagrelor-Based Dual Antiplatelet Therapy to Selective Triple Antithrombotic Therapy for Left Ventricle Dysfunction Following Anterior STEMI. | Sci Rep | 2018 | https://conductscience.org/library/papers/29985433 | PubMed |
| 29886450 | Accuracy, reproducibility and costs of different laboratory assays for the monitoring of unfractionated heparin in clinical practice: a prospective evaluation study and survey among Swiss institutions. | BMJ Open | 2018 | https://conductscience.org/library/papers/29886450 | PubMed |
| 28396990 | Incidence and outcomes of early left ventricular thrombus following ST-elevation myocardial infarction treated with primary percutaneous coronary intervention. | Clin Res Cardiol | 2017 | https://conductscience.org/library/papers/28396990 | PubMed |
| 28197053 | Large In-transient Left Ventricular Thrombus due to Anabolic Steroid-induced Cardiomyopathy. | Indian J Crit Care Med | 2017 | https://conductscience.org/library/papers/28197053 | PubMed |
| 27766063 | Aspirin plus tirofiban inhibit the thrombosis induced by Russell's viper venom. | Thromb J | 2016 | https://conductscience.org/library/papers/27766063 | PubMed |
| 27698506 | Comparison of Time to Therapeutic aPTT in Patients Who Received Continuous Unfractionated Heparin After Implementation of Pharmacy-wide Intervention Alerts. | Hosp Pharm | 2016 | https://conductscience.org/library/papers/27698506 | PubMed |
| 27413043 | Ischemic Stroke Risk After Acute Coronary Syndrome. | J Am Heart Assoc | 2016 | https://conductscience.org/library/papers/27413043 | PubMed |
| 26417910 | Incidence and Predictors of Left Ventricular Thrombus After Primary Percutaneous Coronary Intervention for Anterior ST-Segment Elevation Myocardial Infarction. | Clin Cardiol | 2015 | https://conductscience.org/library/papers/26417910 | PubMed |
| 26365955 | Clinical Characteristics and Risk Factors of Left Ventricular Thrombus after Acute Myocardial Infarction: A Matched Case-control Study. | Chin Med J (Engl) | 2015 | https://conductscience.org/library/papers/26365955 | PubMed |
| 24421495 | High-Risk Non-ST Elevation Acute Coronary Syndrome Outcomes in Patients Treated with Unfractionated Heparin Monitored Using Anti-Xa Concentrations Versus Activated Partial Thromboplastin Time. | Hosp Pharm | 2013 | https://conductscience.org/library/papers/24421495 | PubMed |
| 23730016 | Electrochemical assay of heparin to monitor anticoagulation action in cardiovascular patients. | Indian J Hematol Blood Transfus | 2012 | https://conductscience.org/library/papers/23730016 | PubMed |
| 23687625 | Anticoagulants: A Review of the Pharmacology, Dosing, and Complications. | Curr Emerg Hosp Med Rep | 2013 | https://conductscience.org/library/papers/23687625 | PubMed |
| 23584757 | Mobile left ventricular thrombus in left ventricular dysfunction: case report and review of literature. | Clin Res Cardiol | 2013 | https://conductscience.org/library/papers/23584757 | PubMed |
| 23151669 | Left ventricular thrombus formation after acute myocardial infarction. | Heart | 2012 | https://conductscience.org/library/papers/23151669 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2643772
GET https://conductscience.org/api/papers/v1/2643772/cited_by?page=2